Literature DB >> 20574896

The future of toxicity testing.

Melvin E Andersen1, Mustafa Al-Zoughool, Maxine Croteau, Margit Westphal, Daniel Krewski.   

Abstract

In 2007, the U.S. National Research Council (NRC) released a report, "Toxicity Testing in the 21st Century: A Vision and a Strategy," that proposes a paradigm shift for toxicity testing of environmental agents. The vision is based on the notion that exposure to environmental agents leads to adverse health outcomes through the perturbation of toxicity pathways that are operative in humans. Implementation of the NRC vision will involve a fundamental change in the assessment of toxicity of environmental agents, moving away from adverse health outcomes observed in experimental animals to the identification of critical perturbations of toxicity pathways. Pathway perturbations will be identified using in vitro assays and quantified for dose response using methods in computational toxicology and other recent scientific advances in basic biology. Implementation of the NRC vision will require a major research effort, not unlike that required to successfully map the human genome, extending over 10 to 20 years, involving the broad scientific community to map important toxicity pathways operative in humans. This article provides an overview of the scientific tools and technologies that will form the core of the NRC vision for toxicity testing. Of particular importance will be the development of rapidly performed in vitro screening assays using human cells and cell lines or human tissue surrogates to efficiently identify environmental agents producing critical pathway perturbations. In addition to the overview of the NRC vision, this study documents the reaction by a number of stakeholder groups since 2007, including the scientific, risk assessment, regulatory, and animal welfare communities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574896     DOI: 10.1080/10937404.2010.483933

Source DB:  PubMed          Journal:  J Toxicol Environ Health B Crit Rev        ISSN: 1093-7404            Impact factor:   6.393


  6 in total

1.  Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions as model descriptors.

Authors:  Albert R Cunningham; C Alex Carrasquer; Shahid Qamar; Jon M Maguire; Suzanne L Cunningham; John O Trent
Journal:  Carcinogenesis       Date:  2012-06-07       Impact factor: 4.944

2.  Transcriptome profiling of HepG2 cells exposed to the flame retardant 9,10-dihydro-9-oxa-10-phosphaphenanthrene 10-oxide (DOPO).

Authors:  Boris V Krivoshiev; Gerrit T S Beemster; Katrien Sprangers; Bart Cuypers; Kris Laukens; Ronny Blust; Steven J Husson
Journal:  Toxicol Res (Camb)       Date:  2018-03-12       Impact factor: 3.524

3.  Use of an organotypic mammalian in vitro follicle growth assay to facilitate female reproductive toxicity screening.

Authors:  Yuanming Xu; Francesca E Duncan; Min Xu; Teresa K Woodruff
Journal:  Reprod Fertil Dev       Date:  2015-02-18       Impact factor: 2.311

Review 4.  Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Authors:  Brooke T Mossman; Morton Lippmann; Thomas W Hesterberg; Karl T Kelsey; Aaron Barchowsky; James C Bonner
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 5.  Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways.

Authors:  Sudin Bhattacharya; Qiang Zhang; Paul L Carmichael; Kim Boekelheide; Melvin E Andersen
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

6.  A framework for the next generation of risk science.

Authors:  Daniel Krewski; Margit Westphal; Melvin E Andersen; Gregory M Paoli; Weihsueh A Chiu; Mustafa Al-Zoughool; Maxine C Croteau; Lyle D Burgoon; Ila Cote
Journal:  Environ Health Perspect       Date:  2014-04-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.